Zebrafish_ZeClinics ZECLINICS NEWS

What can you learn from a neuro-pharmacological disease model?

ZeClinics Larvae ZECLINICS NEWS

Dozens of compounds with unknown toxicity profiles in your hands: why entrust the screening to zebrafish?

ZECLINICS NEWS

Can you play with zebrafish genome for drug discovery?

Larvae zebrafish at ZeClinics ZECLINICS NEWS

R&D: What ZeClinics does?

ZECLINICS NEWS

The zebrafish model: A powerful tool for answering complex questions

ZECLINICS NEWS

Statistical Significance in Preclinical Study of Cannabinoid formulations against Parkinson’s Disease in Zebrafish

ZECLINICS NEWS

The Use of Zebrafish Genetics in Eradicating Diseases

ZECLINICS NEWS

Magnolia bark compound discovered to potentially treat drug-resistant epilepsy

ZeClinics DZNE Agreement ZECLINICS NEWS

ZeClinics Partners with German Center for Neurodegenerative Diseases (DZNE)

ZECLINICS NEWS

ZeCardio Therapeutics, spin-out de ZeClinics, abre su ronda de crowdfunding

ZeClinics GRINpatias ZECLINICS NEWS

ZeClinics une esfuerzos con IDIBELL para el estudio de las GRINpatias

CIRSPR CAS 9 ZECLINICS NEWS

Study shows that CRISPR-Cas9 gene editing has a low risk of mistakes in Zebrafish

CNIC HEART REANIMA ZECLINICS NEWS

REANIMA: towards the new horizon of cardiac regeneration

ZECLINICS NEWS

New insights in thalidomide teratogenicity

ZECLINICS NEWS

Zebrafish earn their drug discovery stripes

ZECLINICS NEWS

Increasing the Efficiency of Drug Discovery by Combining Zebrafish and CRISPR/Cas9